Chiara Maria Grana

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

Lisa Bodei, Mark Kidd, Giovanni Paganelli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 466 citations

Medicine, Oncology, Radiation Oncology +7

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Lisa Bodei, Marta Cremonesi, Mahila Ferrari et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 424 citations

Medicine, Nephrology, Nuclear Medicine +17

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 421 citations

Medicine, Nuclear Medicine, Pharmacology +14

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

Lisa Bodei, Marta Cremonesi, Stefania Zoboli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 305 citations

Medicine, Nuclear Medicine, Pharmacology +14

Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

Concetta De Cicco, Marta Cremonesi, Alberto Luini et al. · PubMed · 1998 · 200 citations

Medicine, Nuclear Medicine, Oncology +17